GSK Jan 2024 65.000 call
| Previous close | 0.4000 |
| Open | 0.3000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 65.00 |
| Expiry date | 2024-01-19 |
| Day's range | 0.3000 - 0.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.23k |
- Bloomberg
Advil Maker Haleon Said to Study Potential Deals to Bulk Up
(Bloomberg) -- Haleon Plc, the consumer health business spun out from British pharmaceutical producer GSK Plc, is in the early stages of studying large potential deals to bulk up its brand portfolio, people with knowledge of the matter said. Most Read from BloombergSony Slashes PlayStation VR2 Headset Output After Pre-Orders DisappointTrump Sues Journalist Bob Woodward for Releasing Interview RecordingsWall Street Is Losing Out to Amateur Buyers in the Housing SlumpBrexit Is Costing the UK £100
- Bloomberg
Deutsche Bank, UBS in Focus as Wall Street Sends Mixed Signals
(Bloomberg) -- As earnings season gathers pace, a slew of weak results and a hawkish European Central Bank risk spoiling the rally that spurred European equities to their best-ever start to a year. Most Read from BloombergAdani Rout Hits $68 Billion as Fight With Hindenburg IntensifiesAdani Tries to Calm Investors With 413-Page Hindenburg RebuttalWall Street Is Losing Out to Amateur Buyers in the Housing SlumpHistoric Crash for Memory Chips Threatens to Wipe Out EarningsRussia Can’t Replace the
- Investing.com
Unilever outperforms, edging higher after naming Hein Schumacher as new CEO
By Geoffrey Smith
